Here’s a bold statement: Hormone therapy for menopause, often shrouded in fear and misinformation, might not be the health risk many believe it to be. But here’s where it gets controversial—a groundbreaking Danish study involving over 800,000 women has found no link between menopausal hormone therapy (HRT) and an increased risk of death. Published in The BMJ, this research aligns with current guidelines recommending HRT for women experiencing moderate to severe menopause symptoms, provided they have no medical contraindications.
Menopause can bring a host of uncomfortable symptoms, from hot flashes and sleep disturbances to mood swings and depression. HRT has long been a go-to solution, but its use has plummeted over the past two decades due to safety concerns. And this is the part most people miss—real-world evidence on its long-term effects, especially on mortality, has been lacking until now.
The Danish study tracked women born between 1950 and 1977, excluding those with conditions like blood clots, liver disease, or certain cancers, as well as those who had previously used HRT or undergone bilateral oophorectomy (removal of both ovaries). Researchers followed these women from their 45th birthday until July 2023, accounting for factors like age, education, income, and underlying health conditions.
Of the 876,805 women analyzed, 11.9% used HRT, with a median usage of 1.7 years. While initial data suggested a higher death rate among HRT users (54.9 deaths per 10,000 person-years vs. 35.5 for non-users), this gap disappeared when adjusting for influential factors. Even long-term use (10+ years) showed no increased risk of death. Here’s the kicker—women who underwent bilateral oophorectomy for non-cancerous reasons saw a 27-34% lower risk of death when using HRT, sparking debate about whether more women should consider this therapy post-surgery.
The study also hinted that transdermal HRT (patches or gels) might carry a slightly lower risk compared to no treatment, though researchers caution this needs further investigation. While this is an observational study and can’t prove causation, its large scale and robust methodology make the findings compelling.
Now, let’s stir the pot—if HRT isn’t the villain it’s been painted as, why has fear dominated the narrative? Could societal stigma around menopause and women’s health be to blame? And should more women be reconsidering HRT as a viable option? Share your thoughts below—let’s keep the conversation going.
